Monday, May 20, 2024

Latest Medicine For Hepatitis B

What Treatments Are Available For Chronic Hepatitis B

Treatment of Hepatitis B 2021: Easy to Treat, Hard to Understand!

Hepatitis B

Hepatitis B treatment is based on the results of blood tests, age, and the degree of scarring in the liver. Hepatitis B treatment is recommended for patients with very active virus and an inflamed liver. People with chronic hepatitis B and cirrhosis also may be candidates for treatment.

Treatment involves taking an oral antiviral medication. In some cases, injections may be used.

New Treatment For Hepatitis B With Vaccine

31 January, 2022

New trials published with hepatitis B patients suggests the use of liposome nanoparticles with virus antigens for their treatment.


It is estimated that in the world, about 240 million people have chronic hepatitis B and that 4.7 million new cases are diagnosed annually. Since chronic hepatitis B is responsible for 30% of liver cirrhosis and 53% of liver cancer, the World Health Organization has set a goal of eliminating chronic hepatitis B by 2030.

In this sense, there is a very useful vaccine to prevent hepatitis B virus infection but, although there are effective antiviral drugs to prevent liver damage caused by hepatitis B virus, there are no treatments capable of eliminating the virus.

In an infected person, a correct immune response is essential to eliminate the hepatitis B virus, and so, different therapeutic vaccines are being developed. A clinical trial assessing liposome nanoparticles that carry hepatitis B virus antigens within them and that are capable of significantly increase defenses against the virus, has been published in the journal Hepatology.

The study included 354 patients with chronic hepatitis B, 235 of them receiving 6 subcutaneous injections of therapeutic liposomal nanoparticles at 0, 4, 8, 12, 20 and 28 weeks, while the other 119 patients were injected with placebo . It was found that 18% of the patients responded to the therapeutic vaccine treatment compared to 5% of those who received the placebo.

What Is The Difference Between Acute And Chronic Hbv

Acute HBV lasts for a short time. A person has chronic HBV when they have had the infection for 6 months or more. A person with chronic HBV might carry the infection indefinitely.

Acute HBV can develop into chronic HBV. A persons risk of developing chronic HBV is relative to the age at which they first developed the infection.

Newborns and young children with HBV have a higher risk of developing a chronic infection. According to the :

  • around 9 in 10 infants with acute HBV will develop chronic HBV
  • roughly 1 in 3 children who contract the infection before the age of 6 will develop chronic HBV
  • almost all adults and children older than 6 with HBV will recover completely
  • eating a nutritious diet

People with more severe symptoms may need to go to the hospital.

Doctors recommend having regular blood tests to check whether the infection has resolved or developed into chronic HBV.

Recommended Reading: How Do You Get Hepatitis Ab And C

Persons With Chronic Diseases

Refer to Immunization of Persons with Chronic Diseases in Part 3 for additional general information about vaccination of people with chronic diseases.

Chronic renal disease and patients on dialysis

People with chronic renal disease may respond sub-optimally to HB vaccine and experience more rapid decline of anti-HBs titres, and are therefore recommended immunization with a higher vaccine dose. Individuals undergoing chronic dialysis are also at increased risk for HB infection. In people with chronic renal disease anti-HBs titre should be evaluated annually and booster doses using a higher vaccine dose should be given as necessary.

Neurologic disorders

People with conditions such as autism spectrum disorders or demyelinating disorders should receive all routinely recommended immunizations, including HB-containing vaccine.

Chronic liver disease

HB immunization is recommended for non-immune persons with chronic liver disease, including those infected with hepatitis C, because they are at risk of more severe disease if infection occurs. Vaccination should be completed early in the course of the disease, as the immune response to vaccine is suboptimal in advanced liver disease. Post-immunization serologic testing may be used to confirm vaccine response.

Non-malignant hematologic disorders

Persons with bleeding disorders and other people receiving repeated infusions of blood or blood products are considered to be at higher risk of contracting HB and should be offered HB vaccine.

What Treatments Are Available For Chronic Hepatitis B If Medications Dont Work

Hepatitis B Medicine

If you have advanced hepatitis B, you might also become a candidate for a liver transplant. This path does not always result in a cure because the virus continues in your bloodstream after a transplant. To prevent being infected again after your transplant, you may be prescribed hepatitis B immunoglobulin with an antiviral agent.

Recommended Reading: What Does Hepatitis C Cause

The Hepatitis B Vaccine

Getting the hepatitis B vaccine is one of the most effective ways to prevent hepatitis B. Its usually administered in two, three, or four doses. In many countries, infants receive their first dose of the vaccine at birth.

The Centers for Disease Control and Prevention recommends that infants receive their first dose of the vaccine at birth and finish all doses at 6 to 18 months old.

The CDC also recommends all children under the age of 19 years old be vaccinated if they havent already received the vaccination.

Adults can also get the hepatitis B vaccine. The vaccine is generally recommended if you have an increased risk of contracting the virus. Some of these risk factors include:

  • traveling to or living in a region where hepatitis B is common
  • being sexually active with more than one partner or with a partner who has hepatitis B
  • working in a medical setting or other workplaces where youre exposed to bodily fluids
  • using intravenous drugs and sharing drug equipment
  • having chronic liver disease, a human immunodeficiency virus infection, a hepatitis C infection, diabetes, or kidney disease on dialysis

If youve been exposed to the hepatitis B virus and havent been vaccinated, try to see a doctor right away. They can administer the first dose of the vaccine, though youll need to follow up to receive the remaining doses over the next few months.

They may also prescribe a medication called

Clearing Acute Hepatitis B

Some studies suggest that up to 95% of adults with acute HBV infection will spontaneously clear the virus, usually within six months, with no lasting repercussions.

Chronic hepatitis B occurs when the immune system does not clear the virus. Around one of every 20 people acutely infected with HBV will progress to this persistent stage of infection.

Chronic hepatitis B is a slowly progressive disease in which ongoing inflammation causes the gradual scarring of the liver. This can lead to cirrhosis and hepatocellular carcinoma .

However, the course of chronic HBV infection is not set. Some people may progress faster than others, while others may never develop overt symptoms.

Statistically speaking:

  • The risk of cirrhosis in people with chronic hepatitis B is approximately 10% to 20% over 20 years, increasing to 40% after 30 years.
  • The risk of hepatocellular carcinoma increases by 2% and 3% per year in people with HBV and cirrhosis. People without cirrhosis can also get it, but the annual risk drops to around 0.02%.

You May Like: How Do You Get Hepatitis A And B

Who Should Get The Hepatitis B Vaccine

All newborn babies should get vaccinated. You should also get the shot if you:

  • Come in contact with infected blood or body fluids of friends or family members
  • Use needles to take recreational drugs
  • Have sex with more than one person
  • Are a health care worker
  • Work in a day-care center, school, or jail

New Immunotherapy ‘highly Effective’ Against Hepatitis B

Clinical trial investigates possibility of stopping medication as cure for Hepatitis B
University College London
Scientists have identified a new immunotherapy to combat the hepatitis B virus , the most common cause of liver cancer in the world.

Scientists at UCL have identified a new immunotherapy to combat the hepatitis B virus , the most common cause of liver cancer in the world.

Each year, globally, chronic HBV causes an estimated 880,000 deaths from liver cirrhosis and hepatocellular carcinoma/liver cancer .

The pioneering study used immune cells isolated directly from patient liver and tumour tissue, to show that targeting acyl-CoA:cholesterol acyltransferase , an enzyme that helps to manage cholesterol levels in cells*, was highly effective at boosting immune responses.

Published in Nature Communications, the findings show that blocking the activity of ACAT with ACAT inhibitors boosts the specific immune cells that can fight both the virus and associated cancerous tumours, demonstrating its effectiveness as an immunotherapy. Inhibiting ACAT was also found to impede HBV’s own replication, thereby also acting as a direct antiviral. ACAT inhibitors such as avasimibe, taken orally, have previously been shown to be well-tolerated as cholesterol-lowering drugs in humans.

Explaining the study, lead author Professor Mala Maini , said: “Chronic hepatitis B virus infection is a major global health problem and the most common cause of liver cancer in the world.

Grant funding came from the Wellcome Trust and Cancer Research UK.

Story Source:

You May Like: What Are The Signs Of Autoimmune Hepatitis

Treating Acute Hepatitis B

In acute cases, symptoms do not usually present themselves and the infection will go away on its own. You or your loved one will be monitored to see if there are any changes to your condition.

However, if there are symptoms, doctors will advise getting sufficient rest and fluid intake, as well as having a well-balanced diet.

You or your loved one might need to be hospitalised and given some treatment if the symptoms do worsen.

The doctor might prescribe an over-the-counter pain reliever for any abdominal pains, or antiviral medications for treating acute liver complications.

Can Hepatitis B Be Controlled By Eating Right And Exercising

It is important that people with liver disease follow a healthy, nutritious diet as outlined by Health Canada in Eating Well with Canadas Food Guide.

Alcohol can also damage the liver so it is best that people with hepatitis B do not drink. Following a healthy lifestyle may also prevent fatty liver disease, another liver disease highly prevalent in Canada.

However, hepatitis B cannot be controlled by healthy eating and exercise alone. Hepatitis B can only be controlled by currently available treatment as prescribed by your doctor. Your doctor will need to do regular blood tests to know how much of the active virus is in your blood . The viral load test is used to monitor and manage hepatitis B patients. Viral load can tell your doctor if you need treatment for hepatitis B and how well you are responding to treatment.

You May Like: Can You Catch Hepatitis C From Kissing

Durability And Related Factors After Hbsag Clearance

When patients with HBeAg-positive CHB achieve a satisfactory antiviral treatment endpoint , the clinical recurrence is 2040%, and the virological recurrence can be as high as 8090% after drug withdrawal . Because the safety of drug withdrawal is uncertain, HBsAg clearance is recommended as the ideal treatment endpoint for CHB patients. The accessibility and rate of HBsAg clearance was mentioned above, but the durability of HBsAg clearance after treatment cessation remains controversial.

HBeAg status should also receive attention in the pursuit of HBsAg clearance. The clearance of HBsAg in most patients is based on HBV DNA suppression and HBeAg seroconversion, but a few patients exhibit different HBsAg response patterns, such as HBsAg clearance without HBeAg seroconversion. Only HBsAg clearance based on HBV DNA suppression and HBeAg seroconversion is safe for drug withdrawal .

For Media And Investors Only


Issued: London, UK

  • Phase 2a data to be presented at The Digital International Liver Congress suggests potential of investigational drug to suppress hepatitis B virus after four weeks of treatment.
  • Using pioneering antisense technology GSK836 delivered anti-viral activity, marking a potential step forward toward the goal of assessing a functional cure for people with chronic hepatitis B.
  • GSK836 is on track to start a phase 2b programme by the end of 2020.

GSK today announced that GSK836 , an investigational antisense oligonucleotide, showed marked reductions in hepatitis B surface antigen and hepatitis B virus DNA compared with placebo after four weeks treatment in people with chronic hepatitis B on stable nucleoside or nucleotide analogue therapy and in patients who were NA-naïve.

These data from the 31 patients participating in the phase 2a study will be virtually presented at The Digital International Liver Congress 2020.

Chronic hepatitis B is a major global health problem caused by the hepatitis B virus. It is a long-lasting infection that occurs when the bodys immune system is unable to fight off the virus enabling it to persist in the blood and liver. Current treatment options, which include nucleoside/nucleotide analogues, can suppress but not clear the virus, so need to be taken for life.

For the selected 300mg dose of GSK836, reductions in HBsAg were observed in NA-treated and NA-naïve patients :

Recommended Reading: What Is Chronic Hepatitis B

Hepatitis B Cure 2022

hepatitis b cure 2022 | Hepatitis B virus is one of the most prevalent serious liver diseases. The question is whether hepatitis B patient will be cured. What is new in the treatment of hepatitis B virus? Hepatitis B treatment depends on strengthening the bodys immunity and regulating liver enzymes, which helps in strengthening the body to overcome the B virus. That is why we will present to you today The b virus treatment that achieves this.

I was cured of hepatitis B after using this treatment for 9 months, so says one of the hepatitis B virus patients after using the KA HEPA treatment, which is manufactured by the Turkish company Kashgarli Sultan under the supervision of Dr. Marhoba Kashgarli Sultan, who confirmed the ability of the treatment to expel the hepatitis B virus. of blood completely.

Symptoms of hepatitis B:

Before learning about the new treatment for hepatitis B virus 2021-2022, let us know the symptoms of hepatitis B:

  • The body of the patient with hepatitis C suffers from severe weaknesses.
  • It also cuts off from food because of the interruption of appetite for eating.
  • Hepatitis B has complications that lead to various liver diseases.
  • Constant feeling of pain in the joints, muscles and abdomen.
  • The patients temperature is also higher than normal.
  • In addition, the patients urine color changes from normal to gray.
  • Hepatitis B carrier also suffers from various digestive problems.
  • The complications of hepatitis B virus also lead to jaundice and kidney failure.

What Is Involved In A Liver Transplant

A liver transplant is considered necessary when the liver is damaged and cannot function or in some cases of liver cancer. Your liver is very important. It is responsible for many functions related to making sure that your body stays healthy and is able to digest foods.

You may be eligible for a transplant if you have chronic hepatitis B infection or some of the diseases that may result from it, including liver cancer and cirrhosis. You will have to complete testing and be evaluated before being approved for a transplant. It is likely that you will be placed on a waiting list while an appropriate organ is found.

Donated livers come from two types of donors: living and deceased. Because the liver can regenerate, it is possible to use part of a liver for transplant. The remaining sections in both the donor and the receiver will grow into livers of adequate size.

People who get liver transplants must take anti-rejection drugs for the rest of their lives. These drugs make you more susceptible to infection. However, liver transplants have become more successful over time and continue to improve.

You May Like: Doctors And Medical Specialists For Hepatitis B

Don’t Miss: Can Hepatitis C Be Transmitted Sexually

Causes Of Hepatitis B

HBV spreads from exposure to blood, semen or other body fluids. This means direct exposure, so factors like sneezing and coughing do not spread the virus to other people.

Some causes include:

  • Unprotected sexual contact with someone who is infected.
  • Sharing non-sterile needles/syringes with someone who is infected.
  • Using items that were used by/on an infected person, but not properly sterilised .
  • Direct contact/exposure to infected fluids and/or open sores/wounds.
  • Being conceived by a mother with hepatitis B.

You might notice that some of these causes are very much similar to the causes of HIV, as they both spread by similar means.

Persons With Inadequate Immunization Records

The Truth about Hepatitis B

Evidence of long term protection against HB has only been demonstrated in individuals who have been vaccinated according to a recommended immunization schedule. Independent of their anti-HBs titres, children and adults lacking adequate documentation of immunization should be considered susceptible and started on an immunization schedule appropriate for their age and risk factors. Refer to Immunization of Persons with Inadequate Immunization Records in Part 3 for additional information.

You May Like: Should I Get Hepatitis B Vaccine

Medical Treatment For Hepatitis A B & C

Treatment for hepatitis A, B, or C is based on which type of hepatitis is present in the bloodstream and the severity of the resulting liver damage. Depending on the results of diagnostic tests, our specialists at NYU Langone may recommend antiviral medication to stop the virus from replicating and protect your liver from further damage.

Prognosis Improvement After Hbsag Clearance

These related studies provide clear recommendations that patients who achieve HBsAg clearance have favourable clinical outcomes compared to patients who achieve only HBV DNA suppression and HBeAg seroconversion. HBsAg clearance leads to biochemical, virological and liver histological improvements, and it significantly reduces the risk of HCC. However, HCC may occur after HBsAg seroclearance despite it being the ultimate treatment endpoint recommended by current guidelines. The risk factors associated with HCC include the presence of cirrhosis, male sex, and age50 years at the time of HBsAg clearance . Closer attention should be given to patients with one or more of these risk factors.

These high-risk patients should be re-examined in a timely manner even if HBsAg clearance is obtained. These results also suggest that achieving a functional cure early in the absence of cirrhosis results in a better prognosis .

Read Also: How Do You Treat Hepatitis B

Popular Articles
Related news